Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D'Andrea

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
European Urology|May 6, 2026
Re: Artificial Intelligence Tools Expand Scientists' Impact but Contract Science's FocusDavid D'Andrea, Riccardo Campi
European Urology|October 2, 2017
Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant ChemotherapyDavid D'Andrea, Shahrokh F Shariat
European Urology|June 11, 2017
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node InvolvementDavid D'Andrea, Shahrokh F Shariat
European Urology|November 14, 2024
Re: Adhesive Anti-fibrotic Interfaces on Diverse OrgansDavid D'Andrea, Shahrokh F Shariat
European Urology|June 25, 2017
Re: Radiation with or Without Antiandrogen Therapy in Recurrent Prostate CancerDavid D'Andrea, Shahrokh F Shariat
European Urology Oncology|December 16, 2025
Re: M. Roupret, A. Bertaut, G. Pignot, et al. ALBAN (GETUG-AFU 37): A Phase 3, Randomized, Open-label, International Trial of Intravenous Atezolizumab and Intravesical Bacillus Calmette-Guérin (BCG) Versus BCG Alone in BCG-naive High-risk, Non-muscle-invasive bladder cancer (NMIBC). Ann Oncol. In press. https://doi.org/10.1016/j.annonc.2025.09.017David D'Andrea, Shahrokh F Shariat
European Urology|March 26, 2024
Re: Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-year Outcomes from a Randomized Controlled TrialStefano Mancon, Heidemarie Ofner, David D'Andrea
European Urology|September 28, 2020
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled TrialDavid D'Andrea, Benjamin Pradere, Shahrokh F Shariat
Current Opinion in Urology|November 10, 2017
Biomarkers for immunotherapy in urological cancersKilian M Gust, Irene Resch, David D'Andrea
Current Opinion in Urology|May 24, 2016
Update on ablative therapies of renal tumorsDavid D'Andrea, Shahrokh F Shariat, Tobias Klatte
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
European Urology|May 6, 2026
Re: Artificial Intelligence Tools Expand Scientists' Impact but Contract Science's FocusDavid D'Andrea, Riccardo Campi
European Urology|October 2, 2017
Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant ChemotherapyDavid D'Andrea, Shahrokh F Shariat
European Urology|June 11, 2017
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node InvolvementDavid D'Andrea, Shahrokh F Shariat
European Urology|November 14, 2024
Re: Adhesive Anti-fibrotic Interfaces on Diverse OrgansDavid D'Andrea, Shahrokh F Shariat
European Urology|June 25, 2017
Re: Radiation with or Without Antiandrogen Therapy in Recurrent Prostate CancerDavid D'Andrea, Shahrokh F Shariat
European Urology Oncology|December 16, 2025
Re: M. Roupret, A. Bertaut, G. Pignot, et al. ALBAN (GETUG-AFU 37): A Phase 3, Randomized, Open-label, International Trial of Intravenous Atezolizumab and Intravesical Bacillus Calmette-Guérin (BCG) Versus BCG Alone in BCG-naive High-risk, Non-muscle-invasive bladder cancer (NMIBC). Ann Oncol. In press. https://doi.org/10.1016/j.annonc.2025.09.017David D'Andrea, Shahrokh F Shariat
European Urology|March 26, 2024
Re: Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion Versus Open Radical Cystectomy: 3-year Outcomes from a Randomized Controlled TrialStefano Mancon, Heidemarie Ofner, David D'Andrea
European Urology|September 28, 2020
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled TrialDavid D'Andrea, Benjamin Pradere, Shahrokh F Shariat
Current Opinion in Urology|November 10, 2017
Biomarkers for immunotherapy in urological cancersKilian M Gust, Irene Resch, David D'Andrea
Current Opinion in Urology|May 24, 2016
Update on ablative therapies of renal tumorsDavid D'Andrea, Shahrokh F Shariat, Tobias Klatte
Pageof 24